JAMDA Online Original Study| Volume 19, ISSUE 3, P277.e1-277.e8, March 2018

Screening Sarcopenia in Community-Dwelling Older Adults: SARC-F vs SARC-F Combined With Calf Circumference (SARC-CalF)



      To compare the diagnostic value of the 5-component questionnaire that measures strength, assistance walking, rise from a chair, climb stairs, and falls (SARC-F) and SARC-F combined with calf circumference (SARC-CalF) for screening sarcopenia in community-dwelling older adults.


      A diagnostic accuracy study.


      A community in Chengdu, China.


      Older adults aged 60 years or older.


      Muscle mass, muscle strength, and physical performance were estimated using a bioimpedance analysis device, handgrip strength, and gait speed, respectively. Four commonly used diagnostic criteria [European Working Group on Sarcopenia in Older People (EWGSOP), Asian Working Group for Sarcopenia (AWGS), International Working Group on Sarcopenia (IWGS), and Foundation for the National Institutes of Health (FNIH) criteria] were applied as the reference standard, separately. The sensitivity/specificity analyses of the SARC-F and SARC-CalF methods were evaluated. The receiver operating characteristics curves and the area under the receiver operating characteristics curves were used to compare the overall diagnostic accuracy of the SARC-F and SARC-CalF for identifying sarcopenia.


      We included 160 men and 224 women. Based on the 4 diagnostic criteria, the prevalence of sarcopenia ranged from 11.7% to 25.0%. Using the AWGS criteria as the reference standard, the SARC-CalF had a sensitivity of 60.7% and a specificity of 94.7% in the whole study population, whereas the SARC-F had a sensitivity of 29.5% and a specificity of 98.1%. The area under the receiver operating characteristics curves for SARC-CalF and SARC-F were 0.92 (95% confidence interval 0.89‒0.94) and 0.89 (95% confidence interval 0.86‒0.92), respectively (P = .003). We obtained similar results when using the other 3 criteria as the reference standard. Subgroup analyses revealed similar results in both men and women.


      SARC-CalF significantly improves the sensitivity and overall diagnostic accuracy of SARC-F for screening sarcopenia in community-dwelling older adults.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the American Medical Directors Association
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Cederholm T.
        • Morley J.E.
        Sarcopenia: The new definitions.
        Curr Opin Clin Nutr Metab Care. 2015; 18: 1-4
        • Cruz-Jentoft A.J.
        • Landi F.
        • Schneider S.M.
        • et al.
        Prevalence of and interventions for sarcopenia in ageing adults: A systematic review. Report of the international sarcopenia initiative (EWGSOP and IWGS).
        Age Ageing. 2014; 43: 748-759
        • Smoliner C.
        • Sieber C.C.
        • Wirth R.
        Prevalence of sarcopenia in geriatric hospitalized patients.
        J Am Med Dir Assoc. 2014; 15: 267-272
        • Malmstrom T.K.
        • Morley J.E.
        Sarcopenia: The target population.
        J Frailty Aging. 2013; 2: 55-56
        • Cruz-Jentoft A.J.
        Sarcopenia: A clinical review.
        Rev Clin Gerontol. 2013; 23: 267-274
        • Mijnarends D.M.
        • Schols J.
        • Halfens R.J.G.
        • et al.
        Burden-of-illness of Dutch community-dwelling older adults with sarcopenia: Health related outcomes and costs.
        Eur Geriatr Med. 2016; 7: 276-284
      1. Goates S, Du K, Arensberg ME, et al. Cost burden of sarcopenia associated hospitalization in adults by age and race/ethnicity. Value in health 2017; Conference: ISPOR 22nd Annual European Congress. United States. 0 (5) (pp A288).

        • Woo J.
        • Leung J.
        • Morley J.E.
        Validating the SARC-F: A suitable community screening tool for sarcopenia?.
        J Am Med Dir Assoc. 2014; 15: 630-634
        • Barbosa-Silva T.G.
        • Menezes A.M.
        • Bielemann R.M.
        • et al.
        Enhancing SARC-F: Improving sarcopenia screening in the clinical practice.
        J Am Med Dir Assoc. 2016; 17: 1136-1141
        • Malmstrom T.K.
        • Morley J.E.
        SARC-F: A simple questionnaire to rapidly diagnose sarcopenia.
        J Am Med Dir Assoc. 2013; 14: 531-532
        • Cruz-Jentoft A.J.
        • Baeyens J.P.
        • Bauer J.M.
        • et al.
        Sarcopenia: European consensus on definition and diagnosis: Report of the European working group on sarcopenia in older people.
        Age Ageing. 2010; 39: 412-423
        • Chen L.K.
        • Liu L.K.
        • Woo J.
        • et al.
        Sarcopenia in Asia: Consensus report of the Asian working group for sarcopenia.
        J Am Med Dir Assoc. 2014; 15: 95-101
        • Fielding R.A.
        • Vellas B.
        • Evans W.J.
        • et al.
        Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology, and consequences. International working group on sarcopenia.
        J Am Med Dir Assoc. 2011; 12: 249-256
        • Studenski S.A.
        • Peters K.W.
        • Alley D.E.
        • et al.
        The FNIH sarcopenia project: Rationale, study description, conference recommendations, and final estimates.
        J Gerontol Ser A Biol Sci Med Sci. 2014; 69: 547-558
        • Linden A.
        Measuring diagnostic and predictive accuracy in disease management: An introduction to receiver operating characteristic (ROC) analysis.
        J Eval Clin Pract. 2006; 12: 132-139
        • DeLong E.R.
        • DeLong D.M.
        • Clarke-Pearson D.L.
        Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach.
        Biometrics. 1988; 44: 837-845
        • Morley J.E.
        • Abbatecola A.M.
        • Argiles J.M.
        • et al.
        Sarcopenia with limited mobility: An international consensus.
        J Am Med Dir Assoc. 2011; 12: 403-409
        • Muscaritoli M.
        • Anker S.D.
        • Argiles J.
        • et al.
        Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by special interest groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”.
        Clin Nutr. 2010; 29: 154-159
        • Kim H.
        • Hirano H.
        • Edahiro A.
        • et al.
        Sarcopenia: Prevalence and associated factors based on different suggested definitions in community-dwelling older adults.
        Geriatr Gerontol Int. 2016; 16: 110-122
        • Wen X.
        • An P.
        • Chen W.C.
        • et al.
        Comparisons of sarcopenia prevalence based on different diagnostic criteria in Chinese older adults.
        J Nutri Health Aging. 2015; 19: 342-347
        • Ida S.
        • Murata K.
        • Nakadachi D.
        • et al.
        Development of a Japanese version of the SARC-F for diabetic patients: An examination of reliability and validity.
        Aging Clin Exp Res. 2017; 29: 935-942
        • Parra-Rodriguez L.
        • Szlejf C.
        • Garcia-Gonzalez A.I.
        • et al.
        Cross-cultural adaptation and validation of the Spanish-language version of the SARC-F to assess sarcopenia in Mexican community-dwelling older adults.
        J Am Med Dir Assoc. 2016; 17: 1142-1146
        • Wu T.Y.
        • Liaw C.K.
        • Chen F.C.
        • et al.
        Sarcopenia screened with SARC-F questionnaire is associated with quality of life and 4-year mortality.
        J Am Med Dir Assoc. 2016; 17: 1129-1135
        • Malmstrom T.K.
        • Miller D.K.
        • Simonsick E.M.
        • et al.
        SARC-F: A symptom score to predict persons with sarcopenia at risk for poor functional outcomes.
        J Cachexia Sarcopenia Muscle. 2016; 7: 28-36
        • Urzi F.
        • Šimunič B.
        • Buzan E.
        Basis for sarcopenia screening with the SARC-CalF in nursing homes.
        J Am Med Dir Assoc. 2017; 18 (e5–e10): 991
        • Rossi A.P.
        • Micciolo R.
        • Rubele S.
        • et al.
        Assessing the risk of sarcopenia in the elderly: The mini sarcopenia risk assessment (MSRA) questionnaire.
        J Nutri Health Aging. 2017; 21: 743-749
      2. Van Harmelen R, Verreijen AM, Weijs PJ. Sensitivity and specificity of BIA versus dexa for assessment of low appendicular skeletal muscle mass in the diagnosis of sarcopenic obesity. Clin Nutr. 2002;7:1.